{"entity":{"type":"insider","cik":"0001812305","url":"/insider/0001812305","json_url":"/insider/0001812305.json","name":"Levy Guy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":5,"first":"2020-05-15","last":"2026-06-29","span_basis":"filed_date"},"name_variants":[{"name":"Levy Guy","source":"filing","n_filings":5,"first_seen":"2020-05-15","last_seen":"2026-06-29"}],"transactions":[{"id":5763915,"accession":"0001213900-26-072928","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-26-072928","line_url":"/filing/0001213900-26-072928","is_derivative":false,"issuer_cik":"0001657677","issuer_name":"Parabilis Medicines, Inc.","issuer_ticker":"PBLS","issuer_name_source":null,"issuer_url":"/issuer/0001657677","owner_cik":null,"owner_name":"Soleus Capital, LLC; Soleus Capital Master Fund, L.P.; Soleus Capital Group, LLC; Soleus GP, LLC; Levy Guy; Soleus PE GP III, LLC; Soleus Private Equity GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Capital Management, L.P.","owner_display_name":"Soleus Capital, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1027000.0,"shares_owned_after_display":"1,027,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-11","filed_date":"2026-06-29","scope":"insider","n_lines":2},{"id":5237765,"accession":"0000899243-21-034323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-034323","line_url":"/filing/0000899243-21-034323","is_derivative":false,"issuer_cik":"0001812305","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001812305","owner_cik":"0001812305","owner_name":"Levy Guy","owner_display_name":"Levy Guy","owner_url":"/insider/0001812305","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":546709.0,"shares_display":"546,709","price_per_share":39.65,"price_display":"39.65","price_state":"stated","total_value":21677011.85,"total_display":"21,677,011.85","total_whole":"21,677,012","shares_owned_after":1167378.0,"shares_owned_after_display":"1,167,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-24","filed_date":"2021-08-26","scope":"insider","n_lines":3},{"id":5276507,"accession":"0000899243-21-024991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-024991","line_url":"/filing/0000899243-21-024991","is_derivative":false,"issuer_cik":"0001812305","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001812305","owner_cik":"0001812305","owner_name":"Levy Guy","owner_display_name":"Levy Guy","owner_url":"/insider/0001812305","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":39.16,"price_display":"39.16","price_state":"stated","total_value":15664000.0,"total_display":"15,664,000.00","total_whole":"15,664,000","shares_owned_after":1453252.0,"shares_owned_after_display":"1,453,252","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider","n_lines":2},{"id":3117776,"accession":"0000899243-20-034835","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-034835","line_url":"/filing/0000899243-20-034835","is_derivative":false,"issuer_cik":"0001812305","issuer_name":"BioAtla, Inc.","issuer_ticker":"BCAB","issuer_name_source":null,"issuer_url":"/issuer/0001812305","owner_cik":"0001812305","owner_name":"Levy Guy","owner_display_name":"Levy Guy","owner_url":"/insider/0001812305","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1388890.0,"shares_display":"1,388,890","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":25000020.0,"total_display":"25,000,020.00","total_whole":"25,000,020","shares_owned_after":1055557.0,"shares_owned_after_display":"1,055,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider","n_lines":2},{"id":2758833,"accession":"0001493152-20-009217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-20-009217","line_url":"/filing/0001493152-20-009217#line-4","is_derivative":false,"issuer_cik":"0001327273","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001327273","owner_cik":null,"owner_name":"Soleus Capital Group, LLC; Soleus Capital Master Fund, L.P.; Soleus Private Equity GP I, LLC; Soleus PE GP I, LLC; Levy Guy; Soleus Private Equity Fund I, L.P.; Soleus Capital, LLC","owner_display_name":"Soleus Capital Group, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16909.0,"shares_display":"16,909","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":270544.0,"total_display":"270,544.00","total_whole":"270,544","shares_owned_after":457421.0,"shares_owned_after_display":"457,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-15","scope":"insider"},{"id":2758828,"accession":"0001493152-20-009217","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-20-009217","line_url":"/filing/0001493152-20-009217#line-3","is_derivative":false,"issuer_cik":"0001327273","issuer_name":"Lyra Therapeutics, Inc.","issuer_ticker":"LYRA","issuer_name_source":null,"issuer_url":"/issuer/0001327273","owner_cik":null,"owner_name":"Soleus Capital Group, LLC; Soleus Capital Master Fund, L.P.; Soleus Private Equity GP I, LLC; Soleus PE GP I, LLC; Levy Guy; Soleus Private Equity Fund I, L.P.; Soleus Capital, LLC","owner_display_name":"Soleus Capital Group, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":155000.0,"shares_display":"155,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2480000.0,"total_display":"2,480,000.00","total_whole":"2,480,000","shares_owned_after":155000.0,"shares_owned_after_display":"155,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001657677","name":"Parabilis Medicines, Inc.","url":"/issuer/0001657677","role":"Ten percent owner","n_filings":1,"first_seen":"2026-06-29","last_seen":"2026-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001826892","name":"BioAtla, Inc.","url":"/issuer/0001826892","role":"Director","n_filings":3,"first_seen":"2020-12-22","last_seen":"2021-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001327273","name":"Lyra Therapeutics, Inc.","url":"/issuer/0001327273","role":"Ten percent owner","n_filings":1,"first_seen":"2020-05-15","last_seen":"2020-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001812305","retrieved_at":"2026-08-24T17:15:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}